All of this is further complicated by the apparent existence of the two functionally distinct CD4+NKG2D+ T cell subpopulations, which could influence the fate of the anti-tumor immune response, that is, to support cytotoxicity versus immunoregulation or vice versa. The gene discussed is CD4; the disease is neoplasm.